Diagnostic and Treatment Guidelines for Bipolar II Disorder with Psychotic Features

Core Diagnostic Principles

A manic episode precipitated by an antidepressant is characterized as substance-induced per DSM-IV-TR, even when it represents unmasking of the underlying disorder or disinhibition secondary to the agent, according to the American Academy of Child and Adolescent Psychiatry 1
The American Academy of Child and Adolescent Psychiatry explicitly states that antidepressants may destabilize mood or incite a manic episode, but this does not change the diagnosis from Bipolar II to Bipolar I 1

Bipolar II with psychotic depression is characterized by psychotic symptoms occurring exclusively during major depressive episodes, whereas Bipolar I disorder may have psychotic symptoms during manic, mixed, or depressive episodes 2
The critical differentiating feature is that Bipolar II hypomanic episodes last ≥4 days, increase functioning, and never include psychotic features, whereas Bipolar I manic episodes last ≥7 days, cause marked impairment, and may include grandiose, religious, or paranoid delusions during mania 2

Antipsychotics are first-line treatment during depressive episodes with psychotic features in Bipolar II, with atypical agents preferred, as recommended by the American Academy of Child and Adolescent Psychiatry 2
Mood stabilizers such as lithium or valproate should be initiated concurrently 2
Risperidone in combination with either lithium or valproate has demonstrated effectiveness in controlled trials for bipolar disorder with psychotic features, according to the Journal of the American Academy of Child and Adolescent Psychiatry 1
Antidepressants should be avoided or used with extreme caution in this patient, given the history of antidepressant-induced mania, as advised by the American Academy of Child and Adolescent Psychiatry 1

Antipsychotics should be discontinued once the psychotic depressive episode resolves in Bipolar II, unlike in Bipolar I where continuation for at least 12 months is recommended 2
Target lithium levels of 0.8-1.2 mEq/L for acute treatment, with baseline labs including CBC, thyroid function, urinalysis, BUN, creatinine, serum calcium, and pregnancy test in females, as recommended by the Praxis Medical Insights 3
Monitor lithium levels, renal and thyroid function, and urinalysis every 3-6 months during maintenance therapy 3

The combination of pharmacotherapy and psychosocial interventions, including psychoeducation, cognitive behavioral therapy, and family interventions, is essential for both acute and maintenance treatment 2
Family-focused psychoeducation about symptom recognition, early warning signs of both depression and hypomania, and medication adherence optimizes long-term outcomes 3

Schedule close follow-up within 1-2 weeks to reassess symptoms, verify medication adherence, and determine if mood symptoms are worsening, stable, or improving 3
Use structured rating scales like the Young Mania Rating Scale (YMRS) at each visit to objectively track any emerging hypomanic or manic symptoms 3
Assess for early warning signs of antidepressant-induced mood destabilization if antidepressants are used, as recommended by the American Academy of Child and Adolescent Psychiatry 1

The presence of psychotic features during depression, combined with antidepressant-induced mania history, indicates higher risk for future mood destabilization and requires aggressive mood stabilization 2